What can a positive THC urine screen establish after a CBD-labeled edible?
In a published case, a 94-year-old woman developed confusion and other symptoms. Five days after admission, a relative told the hospital team that they had given her brownies made with an oil marketed as pure CBD. The timing of that history changed the questions the clinicians were able to ask.
Three pieces of evidence
The relative’s account described what was prepared and why. The label described what the seller represented. The patient’s urine drug screen provided separate evidence consistent with THC exposure. A screen cannot specify the amount in each brownie, when the patient ate it or which batch supplied the detected substance. Those details would call for evidence such as the original packaging, retained product, the full laboratory report and contemporaneous accounts.
How to build the timeline
Record when symptoms appeared, when the product was reportedly given and when urine was collected. Keep the medical findings and the product history in their original sequence. The patient returned to baseline with supportive care, but a single case supplies no general estimate of how often CBD-labeled products contain THC or how often an exposed person will experience the same symptoms.
